Possible role of cellular immunity: a case of cellulitis.
On the basis of the observation that there was a "skip" area in an otherwise diffuse drug eruption where cellulitis had previously occurred, it is theorized that both delayed hypersensitivity type of dermatologic drug reaction and cellulitis share pathogenic mechanisms.
Baddour
L M
LM
Departments of Medicine and Pathology, University of Tennessee Medical Center, Knoxville, TN 37920-6999, USA. lbaddour@mc.utmck.edu
Googe
P B
PB
Prince
T L
TL
D002481:Cellulitis / Q000188:drug therapy / Q000276:immunology*; D002981:Clindamycin / Q000009:adverse effects / Q000627:therapeutic use; D003875:Drug Eruptions; D004359:Drug Therapy, Combination / Q000009:adverse effects / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology*; D008875:Middle Aged; D009254:Nafcillin / Q000009:adverse effects / Q000627:therapeutic use; D010397:Penicillanic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010406:Penicillins / Q000009:adverse effects / Q000627:therapeutic use; D010878:Piperacillin / Q000009:adverse effects / Q000627:therapeutic use; D000078142:Tazobactam; D014640:Vancomycin / Q000009:adverse effects / Q000627:therapeutic use
D004791:Enzyme Inhibitors; D010406:Penicillins; D002981:Clindamycin; D009254:Nafcillin; D014640:Vancomycin; D010397:Penicillanic Acid; D000078142:Tazobactam; D010878:Piperacillin